购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-99(Compound 6)是一种羟基类固醇17β-脱氢酶13(HSD17B13)抑制剂,针对雌二醇的IC50值为≤ 0.1 μM。HSD17B13-IN-99 可用于研究肝病、代谢性疾病、心血管疾病,如NAFLD或NASH,以及药物性肝损伤(DILI)。
HSD17B13-IN-99(Compound 6)是一种羟基类固醇17β-脱氢酶13(HSD17B13)抑制剂,针对雌二醇的IC50值为≤ 0.1 μM。HSD17B13-IN-99 可用于研究肝病、代谢性疾病、心血管疾病,如NAFLD或NASH,以及药物性肝损伤(DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-99 (Compound 6) serves as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC50 value of <0.1 μM for estradiol. This compound is utilized in the study of liver, metabolic, and cardiovascular diseases, including NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
分子量 | 484.43 |
分子式 | C24H19F3N4O4 |
CAS No. | 2849338-46-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容